Author

F. Gusovsky

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

M. E. Bottazzi· 2 shared A. E. Marriott· 1 shared A. Mansour· 1 shared A. Moorhead· 1 shared A. Steven· 1 shared C. Fricks· 1 shared C. M. Wilson· 1 shared C. Poveda· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

M. E. Bottazzi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection

K. Jones, D. M. Nguyen, C. Poveda, J. Pollet, F. Gusovsky, M. E. Bottazzi, P. J. Hotez

This study evaluates the impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection, finding that the treatment better preserves liver health compared to curative doses of benznidazole.

bioRxiv · Jul 11, 2023Pathology

A dirofilariasis mouse model for heartworm preclinical research

A. E. Marriott, J. L. Dagley, S. Hegde, A. Steven, C. Fricks, U. DiCosty, A. Mansour, E. J. Campbell, C. M. Wilson, F. Gusovsky, S. A. Ward, W. D. Hong, P. O'Neill, A. Moorhead, S. McCall, , J. D. Turner

This paper establishes a mouse model for heartworm drug screening, showing it can effectively assess drug efficacy against D. immitis larvae.

bioRxiv · Apr 3, 2023 · PreprintMicrobiology

Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in BALB/c mice.

V. M. Dzul-Huchim, M. J. Ramirez-Sierra, P. P. Martinez-Vega, M. E. Rosado-Vallado, V. E. Arana-Argaez, J. Ortega-Lopez, F. Gusovsky, E. Dumonteil, J. V. Cruz-Chan, P. Hotez, M. E. Bottazzi, L. E. Villanueva Lizama

This study shows that combining low-dose benznidazole with a bivalent recombinant protein vaccine reduces cardiac fibrosis in mice infected with Trypanosoma cruzi.

bioRxiv · Feb 16, 2022Immunology